These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27822568)

  • 1. Random Guess and Wishful Thinking are the Best Blinding Scenarios.
    Bang H
    Contemp Clin Trials Commun; 2016 Aug; 3():117-121. PubMed ID: 27822568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blinding, sham, and treatment effects in randomized controlled trials for back pain in 2000-2019: A review and meta-analytic approach.
    Freed B; Williams B; Situ X; Landsman V; Kim J; Moroz A; Bang H; Park JJ
    Clin Trials; 2021 Jun; 18(3):361-370. PubMed ID: 33478258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A theoretical analysis showed that blinding cannot eliminate potential for bias associated with beliefs about allocation in randomized clinical trials.
    Mathieu E; Herbert RD; McGeechan K; Herbert JJ; Barratt AL
    J Clin Epidemiol; 2014 Jun; 67(6):667-71. PubMed ID: 24767518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintaining the blind in sham controlled interventional trials: lessons from the EPISOD study.
    Cotton P; Pauls Q; Wood A; Durkalski-Mauldin V
    Endosc Int Open; 2019 Nov; 7(11):E1322-E1326. PubMed ID: 31673601
    [No Abstract]   [Full Text] [Related]  

  • 5. Causal inference methods to assess safety upper bounds in randomized trials with noncompliance.
    Wang Y; Berlin JA; Pinheiro J; Wilcox MA
    Clin Trials; 2015 Jun; 12(3):265-75. PubMed ID: 25733675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does different information disclosure on placebo control affect blinding and trial outcomes? A case study of participant information leaflets of randomized placebo-controlled trials of acupuncture.
    Cheon S; Park HJ; Chae Y; Lee H
    BMC Med Res Methodol; 2018 Jan; 18(1):13. PubMed ID: 29347917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of risk of bias in quasi-randomized controlled trials and randomized controlled trials reported in the
    Kim JH; Kim TK; In J; Lee DK; Lee S; Kang H
    Korean J Anesthesiol; 2017 Oct; 70(5):511-519. PubMed ID: 29046770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blinded trials taken to the test: an analysis of randomized clinical trials that report tests for the success of blinding.
    Hróbjartsson A; Forfang E; Haahr MT; Als-Nielsen B; Brorson S
    Int J Epidemiol; 2007 Jun; 36(3):654-63. PubMed ID: 17440024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of blinding on treatment effect size estimate in randomized controlled trials of oral health interventions.
    Saltaji H; Armijo-Olivo S; Cummings GG; Amin M; da Costa BR; Flores-Mir C
    BMC Med Res Methodol; 2018 May; 18(1):42. PubMed ID: 29776394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blinding strategies in the conduct and reporting of a randomized placebo-controlled device trial.
    Houweling AH; Shapiro S; Cohen JM; Kahn SR
    Clin Trials; 2014 Oct; 11(5):547-52. PubMed ID: 24902921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary methodological issues in drug development: the functionality of blinding is poorly studied.
    Bello S
    J Evid Based Med; 2017 Feb; 10(1):61-65. PubMed ID: 27487013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blinding and Randomization.
    Bespalov A; Wicke K; Castagné V
    Handb Exp Pharmacol; 2020; 257():81-100. PubMed ID: 31696347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DEPERROR: Risks of systematic errors in drug and non-drug randomized clinical trials assessing intervention effects in patients with unipolar depression.
    Krogh J; Hjorthøj CR; Jakobsen JC; Lindschou J; Kessing LV; Nordentoft M; Gluud C
    J Affect Disord; 2015 Jul; 179():121-7. PubMed ID: 25863907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of blinding in randomized controlled trials found results inconsistent and questionable.
    Boutron I; Estellat C; Ravaud P
    J Clin Epidemiol; 2005 Dec; 58(12):1220-6. PubMed ID: 16291465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors.
    Haahr MT; Hróbjartsson A
    Clin Trials; 2006; 3(4):360-5. PubMed ID: 17060210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in beliefs identify unblinding in randomized controlled trials: a method to meet CONSORT guidelines.
    Rees JR; Wade TJ; Levy DA; Colford JM; Hilton JF
    Contemp Clin Trials; 2005 Feb; 26(1):25-37. PubMed ID: 15837450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blinding terminology used in reports of randomized controlled trials involving dogs and cats.
    Giuffrida MA; Agnello KA; Brown DC
    J Am Vet Med Assoc; 2012 Nov; 241(9):1221-6. PubMed ID: 23078571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blinding in randomized clinical trials: imposed impartiality.
    Hróbjartsson A; Boutron I
    Clin Pharmacol Ther; 2011 Nov; 90(5):732-6. PubMed ID: 21993424
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.